Clinical Trials Browser

Phase 2 × Pituitary Neoplasms × Temozolomide × Clear all

Pituitary Neoplasms

NCT00601289 2020-07-31

Temozolomide in Treating Patients With Invasive Pituitary Tumors

Adenoma, Basophil, Adenoma, Chromophobe, Adenoma, Acidophil, Pituitary Neoplasms, Prolactinoma, Central Nervous System Neoplasms, Growth Hormone-Secreting Pituitary Adenoma

Clinical Trials

TMZ-Cap

Temozolomide in Treating Patients With Invasive Pituitary Tumors